Indications / Non-small cell lung cancer · Breast cancer · Pancreatic cancer · Colorectal cancer · Acute myeloid leukemia · Chronic myeloid leukemia · Multiple myeloma · Glioblastoma · Glioma · Neuroblastoma · Medulloblastoma · Diffuse midline glioma (DIPG) · Ependymoma · Atypical teratoid rhabdoid tumour (AT/RT) · Childhood acute lymphoblastic leukemia · Ewing sarcoma · Osteosarcoma · Rhabdomyosarcoma
Glioblastoma
IDH-wildtype disease that almost always recurs: EGFR, the blood-brain barrier and cell therapy attempts.
SITC Annual Meeting 2026
4–8 Nov 2026, Phoenix · Journal for ImmunoTherapy of Cancer 14 (Suppl 2 and 3), open access
1,109 regular and 19 late-breaking abstracts are in Crossref as open-access JITC supplement records (CC BY-NC); the supplement may still be filling in.
Indexed in Crossref
22 abstracts matching glioblastoma from the meeting's journal supplement, fetched live from Crossref 2026-11-12 09:59 UTC. This is a keyword search, not the complete abstract book.
- 831Systemic AHR signaling enhances oncolytic Zika virus efficacy against GBMHammad Ur Rehman, Kevin S Cashman, Sweta Ghosh, Venkatakrishna Jala et al.
- 606Transport vehicle-enabled TREM2 agonist therapy potentiates anti-tumor immunity in preclinical mouse models of GBMTyler M Johnston, Yoshinari Osada, Gabrielle Kizeev, Pravesh Gupta et al.
- 669
- 409Ferroptosis induction remodels immune checkpoint protein expression in U87-MG glioblastoma cellsBabajide O Ajayi, Ebenezer Olayinka
- 641Targeting EP4 to prevent radiation-induced immunosuppression in glioblastomaMaria Cecilia Lira, Mara De Martino, Claire I Vanpouille-Box
- 283Tumor-activated alloreactive T cells (TAATs) for glioblastoma treatmentJames C Hornickle, Yasemin Kus, Esraa Ebraheem, Wade Poon et al.
- 354Th1.17-programmed platform for generating potent TILs across glioblastoma and other solid tumorsMithil Soni, Adela Joanta-gomez, Fabio Iwamoto, Pawel Muranski
- 419Retrospective analysis of factors associated with improved outcomes in glioblastoma patients treated with pembrolizumabVayou Chittavong, Sydney E Schultz, Jason N Barreto, Jian Campian
- 1113A patient-specific multicellular glioblastoma model captures neuroimmune crosstalk and immunotherapy resistanceZheng Z Zhong, Emmie J Yao, Ting-Yu Lu, Nancy Zhang et al.
- 68Translational PET imaging of suppressive granulocytic myeloid cells in glioblastomaSydney A Jackson, Virginia Kelly, Bhuvitha Chagantipati, Catherine Yip et al.
- 1159Hypoxia ablation reprograms myeloid antigen presentation and drives cervical lymph node T cell trafficking to sensitize glioblastoma to immune checkpoint blockadeIvana William, Broderick X Turner, Michael A Curran
- 197Chimeric antigen receptor T-cell therapy in glioblastoma: a systematic review and meta analysis of early phase clinical trials with GRADE assessmentVincent Yuan, Ahmed Elhadi, Zaid Hasan, Naima Kebir
- 219Preclinical evaluation of targeting death receptor 5 with CAR T cells in glioblastomaJesse L Rodriguez, Alex Moretti, Xiaogang Zhang, Natalie Cooper et al.
- 2Preclinical modeling of human glioblastoma immunotherapy resistance using a STING pathway defective mouse modelApoorvi Chaudhri, Prafulla C Gokhale, Benajmin Eschle, Maia S Lineberry et al.
- 839IND-enabling nonclinical development of IMGS-203, a novel STING agonist, supports first-in-human translation in glioblastomaAkash R Boda, Christine Gagliardi, Ahmad Salameh, Paul Blezinger et al.
- 947Metabolically optimized CAR T cells via glucose transporter modulation for glioblastoma treatmentSrabasti Sengupta, Adriana Yamaguchi, Anna R Nulk, Emma Redmon et al.
- 1047Alternative splicing-derived tumor-specific antigens as putative immunotherapeutic targets for glioblastomaYufei Cui, Aram Shajii, Michael Scott Regan, Kaitlyn Bootz et al.
- 717Cholesterol-dependent glycolytic shunting through the ABCA1–HMOX1 axis sustains immunosuppressive myeloid fitness in glioblastomaLily H Kim, John H Choi, Ryan Nitta, Andrew Tran et al.
- 507Spatial mapping of glioblastoma tumor-microenvironment: identifying differences in tumor states and immune programs between standard-of-care and immunotherapy treatmentGayatri Kumar, Ali Mohammed Pirani, Pravesh Gupta, Lisa M Norberg et al.
- 1103Macrophage-derived lipid transfer enables metabolic buffering and chemotherapy resistance in glioblastomaAnna R Nulk, Avirup Chakraborty, Emma Redmon, Srabasti Sengupta et al.
- 468Combining linoserpaturev with vascular endothelial growth factor (VEGF) blockade to overcome hypoxia-associated immune suppression in glioblastomaFrancesca Barone, Lucia Andrews, Shangbang Rao, Alexander Ling et al.
- 1176Adoptive immunotherapy with effector T lymphocytes that were generated following cancer neoantigen vaccination of MGMT unmethylated glioblastoma multiforme patients is associated with survival benefitPatrick Grogan, Tolga Tuncer, Navid Redjal, Aaron Mammoser et al.